Loading...

OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer

Immunotherapy has shown promising results in cancer treatment. Research shows that most patients might be resistant to these therapies. So, new immune therapies are needed. OX40 (CD134) and OX40 ligand (OX40L), costimulatory molecules, express on different types of immune cells. The interaction betw...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Deng, Juan, Zhao, Sha, Zhang, Xiaoshen, Jia, Keyi, Wang, Hao, Zhou, Caicun, He, Yayi
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735535/
https://ncbi.nlm.nih.gov/pubmed/31564917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214211
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!